Journal article
A genetic variant in SMAD7 acts as a modifier of LMNA -associated muscular dystrophy, implicating SMAD signaling as a therapeutic target
Science advances, Vol.11(16), eads7903
04/18/2025
DOI: 10.1126/sciadv.ads7903
PMCID: PMC12007578
PMID: 40249815
Abstract
Mutations in LMNA cause multiple types of muscular dystrophy (LMNA-MD). The symptoms of LMNA-MD are highly variable and sensitive to genetic background. To identify genetic contributions to this phenotypic variability, we performed whole-genome sequencing on four siblings possessing the same LMNA mutation with differing degrees of skeletal muscle disease severity. We identified a variant in SMAD7 that segregated with severe muscle disease. To functionally test the SMAD7 variant, we generated a Drosophila model possessing the LMNA mutation and the SMAD7 variant in the orthologous fly genes. The SMAD7 variant increased SMAD signaling and enhanced muscle defects caused by the mutant lamin. Conversely, overexpression of wild-type SMAD7 rescued muscle function. These findings were extended to humans by showing that SMAD signaling is increased in muscle biopsy tissue from individuals with LMNA-MD compared to age-matched controls. Collectively, our findings support SMAD7 as the first functionally tested genetic modifier for LMNA-MD and suggest components of the SMAD pathway as therapeutic targets.
Details
- Title: Subtitle
- A genetic variant in SMAD7 acts as a modifier of LMNA -associated muscular dystrophy, implicating SMAD signaling as a therapeutic target
- Creators
- Nathaniel P Mohar - University of IowaChristopher J Langland - University of IowaZachary Darr - Department of Biochemistry and Molecular Biology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USAJill Viles - Independent researcher, Gowrie, Iowa, USASteven A Moore - University of IowaBenjamin W Darbro - Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USALori L Wallrath - Department of Biochemistry and Molecular Biology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA
- Resource Type
- Journal article
- Publication Details
- Science advances, Vol.11(16), eads7903
- DOI
- 10.1126/sciadv.ads7903
- PMID
- 40249815
- PMCID
- PMC12007578
- NLM abbreviation
- Sci Adv
- ISSN
- 2375-2548
- eISSN
- 2375-2548
- Publisher
- AMER ASSOC ADVANCEMENT SCIENCE; WASHINGTON
- Grant note
- National Institutes of Health-NIAMS grant: R21AR075193 Muscular Dystrophy Association Research Grant: 22-1061420 National Institutes of Health-GM grant: T32GM144636 Paul D. Wellstone Muscular Dystrophy Specialized Research Center NIH grant: 1U54NS053672 American Heart Association Predoctoral Fellowship: 25PRE1373209
This work was supported by the National Institutes of Health-NIAMS grant #R21AR075193 (to L.L.W. and B.W.D.), the Muscular Dystrophy Association Research Grant 22-1061420 (to L.L.W.), the National Institutes of Health-GM grant #T32GM144636 (to N.P.M.), the Paul D. Wellstone Muscular Dystrophy Specialized Research Center NIH grant #1U54NS053672 (to S.A.M.), and the American Heart Association Predoctoral Fellowship 25PRE1373209 (to N.P.M.)
- Language
- English
- Date published
- 04/18/2025
- Academic Unit
- Stead Family Department of Pediatrics; Pathology; Medical Genetics and Genomics; Biochemistry and Molecular Biology; University College Courses
- Record Identifier
- 9984811215202771
Metrics
8 Record Views